COVID-19 Genomics UK (COG-UK) Consortium: Final Report.
Biosurveillance
Coronavirus Disease 2019 (COVID-19)
Genomic Medicine
Pandemic
United Kingdom
Journal
Rand health quarterly
ISSN: 2162-8254
Titre abrégé: Rand Health Q
Pays: United States
ID NLM: 101622976
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
entrez:
14
10
2022
pubmed:
15
10
2022
medline:
15
10
2022
Statut:
epublish
Résumé
The ability to sequence and understand different variants of the SARS-CoV-2 virus and their impact is crucial to inform policy and public health decisions. Soon after the UK went into its first lockdown in March 2020, the CCOVID-19 Genomics UK (COG-UK) Consortium was launched. COG-UK is a collaboration of experts in pathogen genomics including academic institutions, public health agencies, the Wellcome Sanger Institute, NHS Trusts and Lighthouse Labs. RAND Europe evaluated how COG-UK delivered against its objectives, for example how it contributed to advancing scientific knowledge about SARS-CoV-2, informing public health decisions, and providing information that can be used to evaluate the effectiveness of vaccines and treatments. The evaluation also examined the diverse factors that influenced COG-UK progress and impact, including enablers and challenges, and considered implications for the future.
Types de publication
Journal Article
Langues
eng
Pagination
24Informations de copyright
Copyright © 2022 RAND Corporation.